Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device

NCT02590939 is registered in ClinicalTrials.gov with Cefaly Technology as lead sponsor.

NCT NCT02590939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02590939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
Lead sponsor
Cefaly Technology
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2016
Completion date
March 31, 2017
Enrollment
106 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

migraine